GERMANY – HTGF and Hannover Innovations back Rodos BioTarget

Hanover-based Rodos BioTarget has developed TargoSphere, a nanocarrier technology that enables targeted delivery of active agents to the antigen-presenting cells of the immune system. The technology recognizes specific cellular surface structures on the antigen-presenting cells and delivers active agents intracellularly to these crucial immune cells. It's principal development objective is to destroy intracellular reservoirs of HIV and Hepatitis C infections, as well as provoking an effective immune response to various malignancies, such as hepatocellular carcinoma and colorectal adenocarcinoma.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• DACH